Effects of tetrandrine and fangchinoline on human platelet aggregation and thromboxane B2 formation

被引:24
|
作者
Kim, HS
Zhang, YH
Fang, LH
Yun, YP
Lee, HK
机构
[1] Chungbuk Natl Univ, Coll Pharm, Dept Pharmacol, Kaeshin Dong 361763, Cheongju, South Korea
[2] Chungbuk Natl Univ, Coll Med, Dept Pharmacol, Kaeshin Dong 361763, Cheongju, South Korea
[3] Korea Res Inst Biosci & Biotechnol, Nat Prod Biosynth Res Unit, Taejon 305600, South Korea
关键词
fangochinoline; PAF-receptor binding; platelet aggregation; tetrandrine; thromboxane B-2;
D O I
10.1016/S0378-8741(98)00237-2
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Tetrandrine (TET) and fangchinoline (FAN) are two major components of the radix of Stephania tetrandra. The effects of TET and FAN on human platelet aggregation and formation of thromboxane (TX) B-2, a stable metabolite of TXA(2), were examined in the aspect of platelet aggregation. TET and FAN inhibited platelet-activating factor (PAF)-induced human platelet aggregation. IC50 values for TET and FAN were 28.6 +/- 3.24 mu M and 21.7 +/- 2.61 mu M, respectively. In the PAF-receptor binding assay, neither TET nor FAN showed any inhibitory effects on the specific bindings of PAF to its receptor. TET and FAN also inhibited PAF-, thrombin-: and arachidonic acid-induced thromboxane B-2 formation in human washed platelet. These results indicate that TET and FAN inhibit the platelet aggregation by interfering with the intracellular messengers system, but not by inhibiting the binding of PAF to PAF-receptor on the platelet membrane directly, and the suppression of TXA(2) formation by TET and FAN may be responsible for their inhibitory activities on the platelet aggregation and further on the thrombosis. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:241 / 246
页数:6
相关论文
共 50 条
  • [41] THROMBOXANE-B2 GENERATION DURING EXVIVO PLATELET-AGGREGATION
    DECATERINA, R
    GIANNESSI, D
    GAZZETTI, P
    BERNINI, W
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1984, 28 (03): : 185 - 196
  • [42] HUMAN-PLATELET AGGREGATION BY PAF AND THROMBOXANE PRODUCTION
    VIOLI, F
    PRATICO, D
    GHISELLI, A
    ALESSANDRI, C
    CORDOVA, C
    THROMBOSIS RESEARCH, 1987, 48 (02) : 265 - 266
  • [43] Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro
    Bode-Böger, SM
    Böger, RH
    Galland, A
    Frölich, JC
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (02) : 143 - 150
  • [44] TOTAL SYNTHESIS OF THROMBOXANE B2
    NELSON, NA
    JACKSON, RW
    TETRAHEDRON LETTERS, 1976, (37) : 3275 - 3278
  • [45] EFFECTS OF DILTIAZEM ON THROMBOXANE B2 PRODUCTION FROM PLATELET-RICH PLASMA AND WHOLE-BLOOD
    ANFOSSI, G
    TROVATI, M
    MULARONI, E
    MASSUCCO, P
    CAVALOT, F
    MATTIELLO, L
    EMANUELLI, G
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1991, 44 (03): : 149 - 154
  • [46] METABOLISM OF THROMBOXANE B2 IN MAN
    ROBERTS, LJ
    SWEETMAN, BJ
    OATES, JA
    CLINICAL RESEARCH, 1978, 26 (03): : A294 - A294
  • [47] Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro
    S. M. Bode-Böger
    Rainer H. Böger
    Andrea Galland
    Jürgen C. Frölich
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1998, 357 : 143 - 150
  • [48] INHIBITION OF PLATELET-AGGREGATION AND THROMBOXANE FORMATION BY ASPIRIN INVITRO
    LLOYD, JV
    SILS, D
    RODGERS, SE
    BOCHNER, F
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1987, 17 (01): : 147 - 147
  • [49] TESTOSTERONE INCREASES HUMAN PLATELET THROMBOXANE A(2) RECEPTOR DENSITY AND AGGREGATION RESPONSES
    AJAYI, AAL
    MATHUR, R
    HALUSHKA, PV
    CIRCULATION, 1995, 91 (11) : 2742 - 2747
  • [50] Inhibition of cyclooxygenase activity, platelet aggregation and thromboxane B2 production by two environmental toxicants:: m- and o-cresol
    Chan, CP
    Yuan-Soon, H
    Wang, YJ
    Lan, WH
    Chen, LI
    Chen, YJ
    Lin, BR
    Chang, MC
    Jeng, JH
    TOXICOLOGY, 2005, 208 (01) : 95 - 104